GENEREX BIOTECHNOLOGY CORP 4
4 · GENEREX BIOTECHNOLOGY CORP · Filed Apr 1, 2013
Insider Transaction Report
Form 4
FLETCHER MARK
EVP & General Counsel
Transactions
- Award
Common Stock Purchase Option (right to buy)
2013-04-01+5,143,787→ 5,143,787 totalExercise: $0.00From: 2013-04-01Exp: 2018-04-01→ COMMON STOCK (5,143,787 underlying)
Footnotes (1)
- [F1]On March 5, 2013, the Board of Directors of the issuer granted the reporting person options to purchase 5,143,787 shares of the issuer's common stock in lieu of cash payment of deferred compensation, which grant was effective upon the reporting person's execution of a Settlement and Release Agreement with the issuer effective April 1, 2013. The grant was made pursuant to the terms of the issuer's 2006 stock plan.